With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.

The Farapoint device adds another tool to the company’s pulsed field ablation portfolio that could help increase or sustain ...

Boston Scientific is capping off a busy week with a major buyout, entering a deal worth about $14.5 billion to acquire ...

Boston Scientific is spending $14.5 billion in cash and stock to buy Penumbra, another medical-device maker that makes products used in minimally invasive procedures to treat conditions such as ...

Boston Scientific (BSX) on Thursday announced a definitive agreement to acquire Penumbra (PEN) in a cash and stock transaction that values the Alameda-based thrombectomy company at ~$14.5B.

Boston Scientific is purchasing heart-device company Penumbra for roughly $14.5 billion in cash and stock, marking the ...

Revolutionary technologies like pulsed field ablation and structural heart therapies are driving rapid market expansion.